GLP-1 Agonists & Psoriasis Comorbidities

By June 11, 2026Video Pearls

GLP-1 agonists

Psoriasis is more than skin deep—it is a systemic inflammatory condition. Jennifer Soung, MD, FAAD, argues that addressing metabolic health is no longer outside the scope of dermatology; it is essential for clinical success.

In a Next Steps in Derm video interview at our sister conference Skin of Color Update, Dr. Soung dives into:

  • The Weight-Biologic Link: How excess weight directly impacts the efficacy of biologic therapies.
  • GLP-1 Agonists: Incorporating modern weight management tools into the psoriatic care plan.
  • The Patient Conversation: Strategies for broaching the sensitive topic of weight with empathy and clinical precision.
  • Comorbidity Management: A comprehensive look at tackling psoriatic arthritis and metabolic syndrome.

Stop treating the skin in a vacuum. Learn how to optimize your patients’ systemic health for better dermatologic outcomes.